Published: 28 Nov 2016

A network of pharmaceutical companies, led by the Norwegian Contract Development and Manufacturing Organisation Curida, will acquire essential equipment for manufacturing of vaccines, when the production facilities at the Norwegian Institute for Public Health (NIPH) close down in July 2017. […]

read more
Published: 01 Jul 2016

The pharmaceutical Contract Development and Manufacturing Organization Curida has entered into a manufacturing agreement with the Norwegian biotech company PCI Biotech. Curida will manufacture Amphinex, the lead product candidate from PCI Biotech. Amphinex is currently undergoing international clinical trials for […]

read more
Published: 28 Jun 2016

Curida reaches yet another milestone with an achievement of ISO 13485 certification. One of our customers, a global Medical Device company, is pursuing new markets in Asia, where the ISO certification is defined as required by the local authorities. An […]

read more